-The Times of India Multinational stent companies claim that the ceiling price fixed by the National Pharmaceutical Pricing Authority (NPPA) is commercially unviable, but they are selling at far lower prices in much richer countries with smaller markets than India such as Germany, the UK, Italy and many other European countries. A look at the prices of stent brands in these countries shows that people in India have been defrauded of crores...

-The Telegraph New Delhi: The World Health Organisation has announced a plan to approve generic versions of two expensive bio-therapeutic anti-cancer molecules in an effort to make them available to low and middle-income countries. It said it would invite manufacturers to submit applications for pre-qualification of biologically similar versions of rituximab, used to treat chronic lymphocytic leukaemia and non-Hodgkin's lymphoma, and trastuzumab, used to treat breast cancer. The pre-qualification process is a mechanism...

-The Indian Express Prime Minister Narendra Modi wants doctors to prescribe generic medicines over branded ones. KAUNAIN SHERIFF M answers key questions on the pricing of drugs and beyond. * What exactly has Prime Minister Narendra Modi said on generic drugs? Speaking in Surat on April 17, the Prime Minister referred to the Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP), which aims to provide cheaper medical drugs to the people. “In the coming days,...

-The Financial Express Despite the substantial increase in agricultural credit in the past few years, a few states such as Tamil Nadu, Punjab and (pre-division) Andhra Pradesh continue to corner a large part of it, while most poor farmers in Odisha, Chhattisgarh, Jharkhand and Bihar are still deprived of credit for purchase of basic farming inputs. This scenario has undermined the Efficacy of the stepped-up farm credit in boosting agricultural productivity. And...

-The Hindu Business Line Bringing digital banking to Primary Agricultural Cooperative Societies is an important and laudable aspect of the Budget The Budget hides months of discussion, with stakeholders nursing a gamut of interests. This year was no exception and the Budget was an exercise in the accommodation of innumerable expectations; and it is bound to dissatisfy many. I would like to apply the old economic litmus test to judge its Efficacy: Is...